#USA #St. Louis #Type 2 Diabetes #ACLM #Project Remission

American College of Lifestyle Medicine's Project Remission Recognized for Innovation in Diabetes Care

The American College of Lifestyle Medicine (ACLM) has distinguished itself by receiving an honorable mention in the prestigious Fast Company Innovation by Design Awards for 2026. The accolade is specifically for their innovative initiative, Project Remission, aimed at changing the conversation around type 2 diabetes from mere management to the possibility of remission and restored health.

Established in 2004, ACLM is dedicated to establishing lifestyle medicine as a standard approach in healthcare. With over 100,000 trained professionals and more than 1.75 million hours of accredited education provided through various programs, ACLM has made significant strides in tackling chronic diseases at their core. This recognition by Fast Company highlights their commitment to using comprehensive lifestyle interventions to enhance patient care.

What is Project Remission?

Project Remission is a digital film series created in collaboration with Content With Purpose. This project highlights how evidence-based lifestyle medicine is reshaping the standard care practices for individuals with type 2 diabetes. Traditionally, diabetes management has centered around controlling symptoms; however, the focus of Project Remission is to transition towards healing and health restoration. This shift could indicate a revolution in how healthcare systems approach chronic illnesses.

The series features insightful contributions from clinicians, health systems, educators, and industry leaders who emphasize the integration of the six pillars of lifestyle medicine into patient care. The six pillars include a whole-food, plant-based diet, regular physical activity, adequate sleep, stress management, avoidance of risky substances, and positive social connections. Each component plays a crucial role in not just managing diabetes but potentially putting the disease into remission.

The Importance of Lifestyle Medicine

Dr. John Findley, CEO of ACLM, expressed his gratitude for the recognition received from Fast Company. "Innovation in healthcare goes beyond just technology. It involves rethinking what is possible for patients," he stated. The essence of Project Remission lies in illustrating this very notion—changing the dynamics of type 2 diabetes treatment from long-term management to the hopeful prospect of complete health restoration.

The selection of honorees for the Fast Company Innovation by Design Awards is made by a diverse panel of leading designers, executives, and editorial staff from Fast Company. They seek to honor initiatives that not only challenge convention but also exemplify thoughtful design and practical solutions to pressing issues.

Brendan Vaughan, Editor-in-Chief of Fast Company, commented on the significance of these awards, noting that they recognize ideas that push boundaries and offer new solutions through strategic design. He commended every honoree for demonstrating the transformative power of thoughtful creativity in addressing substantial challenges.

The Future of Diabetes Care

Project Remission poses significant implications for healthcare systems, particularly regarding the treatment of type 2 diabetes—a condition that affects millions worldwide. The initiative sets an example for how healthcare can transition from merely managing diseases to restoring health through lifestyle changes supported by community and healthcare professionals.

The entire Project Remission series is available for viewing to provide insights and knowledge that can empower both patients and healthcare providers. As society begins to understand the impact of lifestyle choices on health, projects like these pave the way for a brighter future in chronic disease management.

To learn more about Project Remission and to view the series, please visit the official ACLM website or fastcompany.com for more updates regarding the Innovation by Design Awards.

In conclusion, the recognition of ACLM and its Project Remission demonstrates a vital shift in healthcare, blending innovation with a holistic approach to patient wellness. As lifestyle medicine continues to gain traction and legitimacy, the hope for diabetes remission becomes increasingly attainable.